Şunu aradınız:: priestraukuliniai (Litvanca - İngilizce)

priestraukuliniai vaistai
anticonvulsants

7 priestraukuliniai preparataifenobarbitalis fenitoinas karbamazepinasfenobarbitalis, fenitoinas ir karbamazepinas yra cyp450 ferment induktoriai.
phenobarbital, phenytoin and carbamazepine are inducers of cyp450 enzymes.

-kiti receptiniai vaistai (pvz. lytiniai steroidai, kortikosteroidai, priestraukuliniai vaistai ar
-other prescription medicines (e. g. sex steroids, corticosteroids, anticonvulsants or cyclosporine) ,

priestraukuliniai vaistai (fenobarbitalis, fenitoinas, karbamazepinas) .indukuoja cyp3a4 ir gali sumazinti lopinaviro koncentracij.
anticonvulsants (phenobarbital, phenytoin, carbamazepine): will induce cyp3a4 and may decrease lopinavir concentrations.

27 kiti priestraukuliniai vaistai.nra duomen apie galim efavirenzo ir fenitoino, fenobarbitalio ar kit priestraukulini vaist, kurie yra cyp450 izoferment substratai, sveik.
other anticonvulsants: no data are available on the potential interactions of efavirenz with phenytoin, phenobarbital, or other anticonvulsants that are substrates of cyp450 isozymes.

kiti priestraukuliniai vaistai.nra duomen apie galim efavirenzo ir fenitoino, fenobarbitalio ar kit priestraukulini vaist, kurie yra cyp450 izoferment substratai, sveik.efavirenzo vartojant kartu
other anticonvulsants: no data are available on the potential interactions of efavirenz with phenytoin, phenobarbital, or other anticonvulsants that are substrates of cyp450 isozymes.

pries skiriant busilvex jums bus skiriami: ­ priestraukuliniai vaistai traukuli profilaktikai (fenitoinas ar benzodiazepinai) , ­ vmim slopinantys vaistai vmimo profilaktikai.
before receiving busilvex, you will be medicated with-anticonvulsive drugs to prevent seizures (phenytoin or benzodiazepines) and

nra duomen apie bet kurio kartu vartojamo vaistinio preparato didesni dozi skyrim, todl nra dozavimo rekomendacij, ir reikia pagalvoti apie alternatyv priestraukulin gydym.
there are no data with co-administration of higher doses of either medicinal product; therefore, no dose recommendation can be made, and alternative anticonvulsant treatment should be considered.